Cross-linking of T cell to B cell lymphoma by the T cell bispecific antibody CD20-TCB induces IFNγ/CXCL10-dependent peripheral T cell recruitment in humanized murine model
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cross-linking of T cell to B cell lymphoma by the T cell bispecific antibody CD20-TCB induces IFNγ/CXCL10-dependent peripheral T cell recruitment in humanized murine model
Authors
Keywords
Cancers and neoplasms, Synapses, Cytotoxic T cells, Cancer treatment, Mouse models, Cytokines, Intradermal injections, Intravenous injections
Journal
PLoS One
Volume 16, Issue 1, Pages e0241091
Publisher
Public Library of Science (PLoS)
Online
2021-01-07
DOI
10.1371/journal.pone.0241091
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies
- (2020) Andreas Viardot et al. ANNALS OF HEMATOLOGY
- Actin Cytoskeleton Straddling the Immunological Synapse between Cytotoxic Lymphocytes and Cancer Cells
- (2019) Hannah Wurzer et al. Cells
- CD20-TCB (RG6026), A NOVEL “2:1” FORMAT T-CELL-ENGAGING BISPECIFIC ANTIBODY, INDUCES COMPLETE REMISSIONS IN RELAPSED/REFRACTORY B-CELL NON-HODGKIN'S LYMPHOMA
- (2019) M.J. Dickinson et al. HEMATOLOGICAL ONCOLOGY
- T Cell–Activating Bispecific Antibodies in Cancer Therapy
- (2019) Asaad Trabolsi et al. JOURNAL OF IMMUNOLOGY
- CD20-TCB, a Novel T-Cell-Engaging Bispecific Antibody, Induces T-Cell-Mediated Killing in Relapsed or Refractory Non-Hodgkin Lymphoma: Biomarker Results From a Phase I Dose-Escalation Trial
- (2019) Ann-Marie E Bröske et al. BLOOD
- CD20-TCB, a Novel T-Cell-Engaging Bispecific Antibody, Can be Safely Combined with the Anti-PD-L1 Antibody Atezolizumab in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
- (2019) Martin Hutchings et al. BLOOD
- Dual CD20-Targeted Therapy With Concurrent CD20-TCB and Obinutuzumab Shows Highly Promising Clinical Activity and Manageable Safety in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: Preliminary Results From a Phase Ib Trial
- (2019) Franck Morschhauser et al. BLOOD
- CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
- (2018) Ryuma Tokunaga et al. CANCER TREATMENT REVIEWS
- IFN-γ-induced chemokines are required for CXCR3-mediated T cell recruitment and anti-tumor efficacy of anti-HER2/CD3 bispecific antibody
- (2018) Ji Li et al. CLINICAL CANCER RESEARCH
- CD20-TCB with obinutuzumab pretreatment as next generation treatment of hematological malignancies
- (2018) Marina Bacac et al. CLINICAL CANCER RESEARCH
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands
- (2018) Mieke Metzemaekers et al. Frontiers in Immunology
- Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy
- (2018) Timothy M. Pierpont et al. Frontiers in Oncology
- Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice
- (2018) Grégory Ehx et al. Frontiers in Immunology
- Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma
- (2018) Jun Zhang et al. Frontiers in Oncology
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- In Vivo Imaging Sheds Light on Immune Cell Migration and Function in Cancer
- (2017) Tommaso Torcellan et al. Frontiers in Immunology
- Diffuse Large B-Cell Lymphoma: Current Strategies and Future Directions
- (2017) Jennifer L. Cultrera et al. Cancer Control
- Clinical approach to diffuse large B cell lymphoma
- (2016) Paolo F. Caimi et al. BLOOD REVIEWS
- CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
- (2016) Holger Bronger et al. BRITISH JOURNAL OF CANCER
- 2016 US lymphoid malignancy statistics by World Health Organization subtypes
- (2016) Lauren R. Teras et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors
- (2016) M. Bacac et al. CLINICAL CANCER RESEARCH
- In Vivo Fluorescence Imaging of the Activity of CEA TCB, a Novel T-Cell Bispecific Antibody, Reveals Highly Specific Tumor Targeting and Fast Induction of T-Cell-Mediated Tumor Killing
- (2016) S. Lehmann et al. CLINICAL CANCER RESEARCH
- The cytotoxic T lymphocyte immune synapse at a glance
- (2016) Nele M. G. Dieckmann et al. JOURNAL OF CELL SCIENCE
- CEA TCB: A novel head-to-tail 2:1 T cell bispecific antibody for treatment of CEA-positive solid tumors
- (2016) Marina Bacac et al. OncoImmunology
- Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints
- (2015) M. E. Mikucki et al. Nature Communications
- Bispecific T-cell engagers for cancer immunotherapy
- (2014) Amelia M Huehls et al. IMMUNOLOGY AND CELL BIOLOGY
- The Immunological Synapse
- (2014) M. L. Dustin Cancer Immunology Research
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
- (2012) Tadashi Yokosuka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The emerging role of CXCL10 in cancer (Review)
- (2011) MINGLI LIU et al. Oncology Letters
- Sustained LFA-1 cluster formation in the immune synapse requires the combined activities of L-plastin and calmodulin
- (2010) Guido H. Wabnitz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Intravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategies
- (2009) Gudrun E. Koehl et al. CLINICAL & EXPERIMENTAL METASTASIS
- Mode of cytotoxic action of T cell-engaging BiTE antibody MT110
- (2009) Cornelia Haas et al. IMMUNOBIOLOGY
- Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice
- (2008) Béatrice Breart et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulatory T Cells: Mechanisms of Differentiation and Function
- (2007) Steven Z. Josefowicz et al. Annual Review of Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now